Feed

Latest Intelligence

Every AI development we have covered, newest first. Filter by section to focus on what matters to you.

TechCrunchAug 22, 2026Business

OpenAI says California should strengthen its AI safety bill

OpenAI has publicly urged California lawmakers to strengthen Senate Bill 53, an AI safety legislative proposal. The stance marks a strategic shift for the company, which previously opposed the measure. The engagement highlights increasing industry involvement in shaping state-level AI safety mandates, risk management standards, and operational obligations for leading artificial intelligence developers operating within the state.

33/100

TechCrunchAug 22, 2026Regulation

Frontier AI labs still won’t say how they’d contain a rogue model

A newly published study indicates that major frontier artificial intelligence developers lack comprehensive, publicly documented containment protocols for rogue or misaligned models. While leading organizations continue to advance frontier model capabilities and autonomous agents, the research highlights a systemic deficit in transparent incident response frameworks designed to halt or isolate models demonstrating unintended, high-risk, or uncontrollable behaviors during operation.

39/100

SiliconANGLEAug 21, 2026Business

Politics hits data centers, OpenAI falls behind Anthropic and now AI is too big to fail… quietly

AI infrastructure expansion faces increasing political and community resistance as public opposition to local data center construction intensifies. Citing polling data showing significant local opposition outranking traditional industrial concerns, market analysis also highlights shifting competitive dynamics between leading frontier model developers OpenAI and Anthropic. The intersection of rising energy demands, local zoning pushback, and heavy capital commitments is elevating AI infrastructure from a technical consideration to a prominent public policy and macroeconomic risk.

49/100

MIT Technology ReviewAug 21, 2026Business

The Download: threats from space mirrors and credit for AI drugs

MIT Technology Review highlights emerging debates regarding intellectual property attribution and scientific credit for pharmaceuticals developed using artificial intelligence. As computational platforms take on greater roles in identifying and optimizing candidate molecules, life sciences organizations face growing ambiguity over patent inventorship requirements, balancing contributions between human researchers and generative design algorithms across drug discovery pipelines.

21/100

MIT Technology ReviewAug 21, 2026Business

When AI designs a drug, who gets the credit?

Biotechnology companies such as Insilico Medicine are leveraging generative AI platforms to design novel therapeutic molecules, including candidate treatments for pulmonary fibrosis. As machine learning systems take on primary roles in proposing chemical structures, ambiguity arises over legal inventorship, scientific attribution, and intellectual property eligibility. Global patent authorities and pharmaceutical firms must address how algorithmic drug designs align with traditional legal requirements that mandate human inventorship.

29/100

Nextgov/FCW (AI)Aug 20, 2026Enterprise

FDA considers doctor-like ‘competency-based’ tests for medical generative AI

Nextgov reports that the FDA and the Trump administration are considering competency-based testing frameworks for generative AI models in healthcare. The regulatory concepts emerge as companies increasingly deploy large language model chatbots for managing patient conditions, including mental health and diabetes.

32/100

The VergeAug 20, 2026Business

It’s Greg Brockman’s OpenAI now

OpenAI cofounder Greg Brockman has taken on an expanded leadership role across the organization as the company prepares for an initial public offering. The leadership consolidation follows a turbulent operational period marked by executive turnover, high-profile litigation involving Elon Musk and Apple, and heightened scrutiny over AI safety. Brockman's elevated remit positions him centrally in steering technical execution, organizational strategy, and corporate governance ahead of OpenAI's planned public listing.

43/100

MIT Technology ReviewAug 20, 2026Regulation

Debates over AI consciousness are a trap

In an opinion piece for MIT Technology Review, AI ethics specialist Rumman Chowdhury argues that focusing on speculative AI consciousness misdirects policy discourse. Chowdhury highlights how tech leaders including Demis Hassabis, Dario Amodei, and Sam Altman promote regulatory attention toward autonomous, runaway systems. The commentary asserts that anthropomorphizing AI agents as sentient or hostile creates a rhetorical trap, diverting regulatory and corporate scrutiny away from practical, immediate AI governance challenges.

17/100

OpenAIAug 20, 2026Business

Introducing AI Futures

OpenAI has launched AI Futures, a dedicated publication series focused on the macroeconomic, societal, and geopolitical implications of advanced artificial intelligence. According to OpenAI, the blog will explore how transformative AI systems may reshape global power structures, institutional governance, economic models, and individual liberties as technological capabilities scale.

18/100

Ars TechnicaAug 19, 2026Business

Flight attendants freaked out that Google is buying tons of Spirit employee data

Bankrupt Spirit Airlines is facing severe pushback from flight attendants and employee representatives over a reported large-scale sale of worker data to Google. The transaction reportedly transfers substantial volumes of personally identifiable information and operational workplace records as part of bankruptcy asset liquidations. The deal has sparked alarm among labour groups and privacy advocates regarding how sensitive enterprise employee records might be integrated, monetised, or utilised across Google's commercial platforms and AI training pipelines.

48/100